Related Experiment Videos
Primary hyperparathyroidism and osteoporosis in 2004
Catherine Cormier1, Jean-Claude Souberbielle, André Kahan
1Rheumatology department A (Prof. A. Kahan), Cochin Teaching Hospital, 27, rue du Faubourg Saint-Jacques 75014, Paris, France. catherine.cormier@cch.ap-hop-paris.fr
Joint Bone Spine
|June 9, 2004
Summary
Diagnosing primary hyperparathyroidism involves careful lab test interpretation, especially when evaluating osteoporosis. Parathyroidectomy is the preferred treatment due to its safety and lack of long-term drug alternatives.
Area of Science:
- Endocrinology
- Metabolic Bone Disease
Background:
- Primary hyperparathyroidism (PHPT) diagnosis is crucial for management.
- Parathyroid hormone (PTH) assays are common in osteoporosis evaluation.
- Interpreting laboratory tests for PHPT requires caution, even with osteoporosis.
Purpose of the Study:
- To outline diagnostic strategies for primary hyperparathyroidism.
- To discuss the role of bone mineral density (BMD) in PHPT management.
- To review treatment options for PHPT.
Main Methods:
- Review of laboratory diagnostic criteria for PHPT.
- Analysis of bone mineral density (BMD) measurements in PHPT patients.
- Evaluation of parathyroidectomy as a treatment option.
Main Results:
- Laboratory tests can suggest PHPT during osteoporosis workup but need careful interpretation.
- Lowered BMD cutoffs in 2003 increased parathyroidectomy rates.
- Parathyroidectomy is effective with low mortality.
Conclusions:
- Accurate diagnosis of primary hyperparathyroidism is essential.
- BMD assessment aids in selecting patients for parathyroidectomy.
- Parathyroidectomy is the recommended treatment for PHPT.